Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives

SE Rebuzzi, R Alfieri, S La Monica, R Minari… - Critical Reviews in …, 2020 - Elsevier
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) improved clinical
outcome compared to chemotherapy in EGFR mutated advanced non-small cell lung cancer …
被引用次数：62 相关文章
[PDF] unipr.it

[PDF][PDF] Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: review of the literature and future perspectives

SE Rebuzzi, R Alfieri, S La Monica, R Minari… - CRITICAL REVIEWS IN …, 2020 - air.unipr.it
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) improved clinical
outcome compared to chemotherapy in EGFR-mutated advanced non-small cell lung cancer …

Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives

SE Rebuzzi, R Alfieri, S La Monica… - Critical reviews in …, 2020 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) improved clinical
outcome compared to chemotherapy in EGFR mutated advanced non-small cell lung cancer …

Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives.

SE Rebuzzi, R Alfieri, S La Monica… - Critical Reviews in …, 2019 - europepmc.org
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) improved clinical
outcome compared to chemotherapy in EGFR mutated advanced non-small cell lung cancer …
[PDF] unipr.it

[PDF][PDF] Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: Review of the literature and future perspectives

SE Rebuzzia, R Alfieric, S La Monicac, R Minaria… - 2023 - air.unipr.it
Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) improved clinical
outcome compared to chemotherapy in EGFR-mutated advanced non-small cell lung cancer …